Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism*

Cyclin D1 encodes a regulatory subunit, which with its cyclin-dependent kinase (Cdk)-binding partner forms a holoenzyme that phosphorylates and inactivates the retinoblastoma protein. In addition to its Cdk binding-dependent functions, cyclin D1 regulates cellular differentiation in part by modifying several transcription factors and nuclear receptors. The molecular mechanism through which cyclin D1 regulates the function of transcription factors involved in cellular differentiation remains to be clarified. The histone acetyltransferase protein p300 is a co-integrator required for regulation of multiple transcription factors. Here we show that cyclin D1 physically interacts with p300 and represses p300 transactivation. We demonstrated further that the interaction of the two proteins occurs at the peroxisome proliferator-activated receptor γ-responsive element of the lipoprotein lipase promoter in the context of the local chromatin structure. We have mapped the domains in p300 and cyclin D1 involved in this interaction. The bromo domain and cysteine- and histidine-rich domains of p300 were required for repression by cyclin D1. Cyclin D1 repression of p300 was independent of the Cdk- and retinoblastoma protein-binding domains of cyclin D1. Cyclin D1 inhibits histone acetyltransferase activity of p300 in vitro. Microarray analysis identified a signature of genes repressed by cyclin D1 and induced by p300 that promotes cellular differentiation and induces cell cycle arrest. Together, our results suggest that cyclin D1 plays an important role in cellular proliferation and differentiation through regulation of p300.

[1]  Mahadev Rao,et al.  Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor γ-mediated Adipogenesis through Histone Deacetylase Recruitment* , 2005, Journal of Biological Chemistry.

[2]  Johan T den Dunnen,et al.  Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.

[3]  W. Gu,et al.  SIRT1 Deacetylation and Repression of p300 Involves Lysine Residues 1020/1024 within the Cell Cycle Regulatory Domain 1* , 2005, Journal of Biological Chemistry.

[4]  A. Muñoz,et al.  The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer , 2005, Oncogene.

[5]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[6]  S. Aaronson,et al.  An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.

[7]  J. Rowley,et al.  Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16) , 2004, Genes, chromosomes & cancer.

[8]  L. Pan,et al.  Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias. , 2004, Cancer letters.

[9]  L. Augenlicht,et al.  Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice , 2004, Molecular and Cellular Biology.

[10]  K. Akashi,et al.  Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.

[11]  C. Caldas,et al.  p300/CBP and cancer , 2004, Oncogene.

[12]  M. Bottomley.  Structures of protein domains that create or recognize histone modifications , 2004, EMBO reports.

[13]  S. Anderson,et al.  Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.

[14]  D. Lacombe,et al.  Analysis of CBP (CREBBP) gene deletions in Rubinstein‐Taybi syndrome patients using real‐time quantitative PCR , 2004, Human mutation.

[15]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Roberto Sanchez,et al.  Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. , 2004, Molecular cell.

[17]  Y. Kanno,et al.  Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. , 2004, Molecular cell.

[18]  E. Rosen,et al.  Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth , 2003, Molecular and Cellular Biology.

[19]  Lawrence A. Donehower,et al.  Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation , 2003, Molecular and Cellular Biology.

[20]  N. Perkins,et al.  p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor , 2003 .

[21]  X. de la Cruz,et al.  The SV40 T antigen modulates CBP histone acetyltransferase activity. , 2003, Nucleic acids research.

[22]  R. Medema,et al.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty , 2003, Journal of leukocyte biology.

[23]  Amanda Y. Chan,et al.  Cyclin D1 governs adhesion and motility of macrophages. , 2003, Molecular Biology of the Cell.

[24]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[25]  R. Weinberg,et al.  Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.

[26]  R. Gaynor,et al.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.

[27]  Yusuke Nakamura,et al.  Involvement of FKHR-Dependent TRADD Expression in Chemotherapeutic Drug-Induced Apoptosis , 2002, Molecular and Cellular Biology.

[28]  I. Roninson,et al.  Induction of Transcription through the p300 CRD1 Motif by p21WAF1/CIP1 Is Core Promoter Specific and Cyclin Dependent Kinase Independent , 2002, Cell cycle.

[29]  M. Lisanti,et al.  Acetylation in hormone signaling and the cell cycle. , 2002, Cytokine & growth factor reviews.

[30]  N. Aoki,et al.  Overexpression and Ribozyme-mediated Targeting of Transcriptional Coactivators CREB-binding Protein and p300 Revealed Their Indispensable Roles in Adipocyte Differentiation through the Regulation of Peroxisome Proliferator-activated Receptor γ* , 2002, The Journal of Biological Chemistry.

[31]  D. Troyer,et al.  Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. , 2002, Cancer research.

[32]  A. Leiter,et al.  Cyclin D1 Represses the Basic Helix-Loop-Helix Transcription Factor, BETA2/NeuroD* , 2002, The Journal of Biological Chemistry.

[33]  E. Schmidt,et al.  IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.

[34]  R. Hynes,et al.  Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Stuart A. Aaronson,et al.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.

[36]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[37]  Michael Kühl,et al.  Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 , 2001, Current Biology.

[38]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[39]  C A Ross,et al.  Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.

[40]  J L Cleveland,et al.  Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. , 2000, Genes & development.

[41]  P. Evans,et al.  The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p , 2000, The EMBO journal.

[42]  L. Donehower,et al.  The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3β and cAMP-responsive Element-binding Protein-dependent Pathways* , 2000, The Journal of Biological Chemistry.

[43]  D. Lacey,et al.  The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development , 2000, Cell.

[44]  V. Ogryzko,et al.  p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.

[45]  R. Goodman,et al.  CBP/p300 in cell growth, transformation, and development. , 2000, Genes & development.

[46]  M. Miyasaka,et al.  Mammary Glands of Aly Mice: Developmental Changes and Lactation‐Related Expression of Specific Proteins, α‐Casein, GlyCAM‐1 and MAdCAM‐1 , 2000, American journal of reproductive immunology.

[47]  A. Harel-Bellan,et al.  CBP/p300 histone acetyl-transferase activity is important for the G1/S transition , 2000, Oncogene.

[48]  Kris Vleminckx,et al.  The p300/CBP acetyltransferases function as transcriptional coactivators of β‐catenin in vertebrates , 2000, The EMBO journal.

[49]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[50]  N. Perkins,et al.  A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation , 2000, Molecular and Cellular Biology.

[51]  R. Eisenman,et al.  Sin Meets NuRD and Other Tails of Repression , 1999, Cell.

[52]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[53]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[54]  Lei Zeng,et al.  Structure and ligand of a histone acetyltransferase bromodomain , 1999, Nature.

[55]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Ewen,et al.  P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Ayer,et al.  Histone deacetylases: transcriptional repression with SINers and NuRDs. , 1999, Trends in cell biology.

[58]  J. Auwerx,et al.  p300 Interacts with the N- and C-terminal Part of PPARγ2 in a Ligand-independent and -dependent Manner, Respectively* , 1999, The Journal of Biological Chemistry.

[59]  Weidong Wang,et al.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. , 1998, Molecular cell.

[60]  D. Livingston,et al.  p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.

[61]  Andrew J. Bannister,et al.  The acetyltransferase activity of CBP stimulates transcription , 1998, The EMBO journal.

[62]  C. Sherr,et al.  Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism , 1998, Molecular and Cellular Biology.

[63]  Robert A. Weinberg,et al.  Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes , 1998, Molecular and Cellular Biology.

[64]  N. Jones,et al.  p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. , 1998, Genes & development.

[65]  Christopher K. Glass,et al.  The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.

[66]  Y. Hayashi,et al.  Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). , 1997, Blood.

[67]  M. Ewen,et al.  Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 , 1997, Molecular and cellular biology.

[68]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[69]  David W. Dawson,et al.  CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.

[70]  F. Zindy,et al.  Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. , 1997, Genes & development.

[71]  G. Nabel,et al.  Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator , 1997, Science.

[72]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[73]  L. Zon,et al.  Induction of cyclin D1 by simian virus 40 small tumor antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Bhattacharya,et al.  Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α , 1996, Nature.

[75]  G. Condorelli,et al.  Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (*) , 1996, The Journal of Biological Chemistry.

[76]  Raoul C. M. Hennekam,et al.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.

[77]  D. Livingston,et al.  A family of transcriptional adaptor proteins targeted by the E1A oncoprotein , 1995, Nature.

[78]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[79]  J B Lawrence,et al.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.

[80]  E. Moran,et al.  DNA-binding properties of the E1A-associated 300-kilodalton protein , 1992, Molecular and cellular biology.

[81]  O. Witte,et al.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias , 1991, Molecular and cellular biology.

[82]  P. Bornstein,et al.  Characterization of the mouse thrombospondin gene and evaluation of the role of the first intron in human gene expression. , 1990, The Journal of biological chemistry.

[83]  M. L. Le Beau,et al.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[84]  P. Yaciuk,et al.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity , 1990, Journal of virology.

[85]  D. Amanatullah,et al.  Ras regulation of cyclin D1 promoter. , 2001, Methods in enzymology.

[86]  N. Kakazu,et al.  Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation , 2001, Leukemia.

[87]  J. Lipsick,et al.  D‐type cyclins repress transcriptional activation by the v‐Myb but not the c‐Myb DNA‐binding domain , 1998, The EMBO journal.